For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are ...

Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.Continued ...

Bryon Daily did not fit the profile of someone at risk for a rare blood condition. After all, he said he was under 60, physically fit, and had no family history of the disease. But after a seemingly ...

Recovery from multiple myeloma leads to a renewed sense of purpose and determination, with hope found in small victories. The ...

2024 was a year of resilience after a myeloma diagnosis, marked by a return to public speaking, a documentary filming experience and a fundraising walk.

They report a concerning relationship between micro and nanoplastic (MNP) concentrations in damaged tissues and links with multiple health conditions. Plastic usage soared from 1.5 million metric ...

CAR T-cell therapy modifies T cells to target cancer, showing promise in multiple myeloma treatment High costs and limited access make advanced cancer therapies unaffordable for many in India ...